BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19149902)

  • 1. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
    Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
    BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
    Kawakami K; Brabender J; Lord RV; Groshen S; Greenwald BD; Krasna MJ; Yin J; Fleisher AS; Abraham JM; Beer DG; Sidransky D; Huss HT; Demeester TR; Eads C; Laird PW; Ilson DH; Kelsen DP; Harpole D; Moore MB; Danenberg KD; Danenberg PV; Meltzer SJ
    J Natl Cancer Inst; 2000 Nov; 92(22):1805-11. PubMed ID: 11078757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus.
    Kim YT; Park JY; Jeon YK; Park SJ; Song JY; Kang CH; Sung SW; Kim JH
    Dis Esophagus; 2009; 22(2):143-50. PubMed ID: 18847451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
    Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of adenomatous polyposis coli(APC) promoter methylation on gene transcription in lung cancer cell lines].
    Zhang LX; Pan SY; Chen D; Xie EF; Gao L; Shu YQ; Lu ZH; Cheng L; Yang D; Zhang JN
    Ai Zheng; 2007 Jun; 26(6):576-80. PubMed ID: 17562260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoallelic methylation of the APC promoter is altered in normal gastric mucosa associated with neoplastic lesions.
    Clément G; Bosman FT; Fontolliet C; Benhattar J
    Cancer Res; 2004 Oct; 64(19):6867-73. PubMed ID: 15466175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
    Haluskova J; Lachvac L; Nagy V
    Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
    Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
    Cong DG; Wang SF
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients].
    Pan SY; Xie EF; Shu YQ; Gao L; Zhang LX; Chen D; Chen JB; Zhao WJ; Mu Y; Zhang JN
    Ai Zheng; 2009 Apr; 28(4):384-9. PubMed ID: 19622298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
    Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
    Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z
    Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.